HHS published an FAQ to clarify how the COVID-19 public health emergency (PHE) conclusion, which is expected to occur on May 11, will impact coverage of testing, treatment, and preventive services.Read More »
HHS released a policy roadmap for providers ahead of the public health emergency (PHE) conclusion. The roadmap details policies that will simultaneously end with the PHE, as well as flexibilities that have been extended for various time periods.Read More »
Over three-quarters of hospitals remain noncompliant with federal price transparency regulations, according to a PatientRightsAdvocate.org report.Read More »
A federal judge remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program. After experiencing several key wins throughout their long legal battle with HHS, the American Hospital Association and other industry plaintiffs were disappointed by the ruling.Read More »
More payers and providers are using the independent dispute resolution (IDR) process than the government anticipated to settle payment for items and services covered by the No Surprises Act.Read More »
